ENTEST GROUP, INC.
company.status.inactiveCIK 1449447fmd_1CVRBVVSSZQYSZY55Q2D1YJGVFManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 01, 2008 to Nov 30, 2019, 39 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total interest income | – | – | – | – | – | – | – | 0 | 0 | – |
| Cost of revenue | – | 0 | 0 | – | – | – | – | – | – | – |
| Net interest income | – | – | – | – | – | – | – | (0) | 0 | – |
| Gross profit | – | 0 | 0 | – | – | – | – | – | – | – |
| Research and development | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | – |
| Operating income | – | (1) | (1) | (1) | (0) | (0) | (1) | (1) | (2) | (0) |
| Interest expense | – | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | (0) | (1) | (1) | (1) | (0) | 0 | (0) | 0 | 0 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 |
| Net income from continuing operations | – | – | (2) | (1) | (1) | (0) | (1) | (1) | (1) | 0 |
| Net income | (1) | (1) | (2) | (1) | (1) | (0) | (1) | (1) | (1) | 0 |
| Net income to common shareholders | – | (1) | (2) | (1) | (1) | (0) | (1) | (1) | (1) | – |